RCKTW logo

Rocket Pharmaceuticals, Inc. Warrant


RCKTW: Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.


Show RCKTW Financials

Consumer Interest
SEC Filings

Recent trades of RCKTW by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by RCKTW's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Gene therapy vectors for treatment of danon disease Jul. 07, 2020
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of RCKTW in WallStreetBets Daily Discussion


Recent insights relating to RCKTW

CNBC Recommendations

Recent picks made for RCKTW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RCKTW

Corporate Flights

Flights by private jets registered to RCKTW